chr16-1202249-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_021098.3(CACNA1H):​c.1799C>T​(p.Ala600Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000287 in 1,567,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000030 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.50

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3509935).
BP6
Variant 16-1202249-C-T is Benign according to our data. Variant chr16-1202249-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 585632.
BS2
High AC in GnomAdExome4 at 42 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.1799C>Tp.Ala600Val
missense
Exon 9 of 35NP_066921.2
CACNA1H
NM_001005407.2
c.1799C>Tp.Ala600Val
missense
Exon 9 of 34NP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.1799C>Tp.Ala600Val
missense
Exon 9 of 35ENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.1799C>Tp.Ala600Val
missense
Exon 9 of 34ENSP00000454990.2
CACNA1H
ENST00000711493.1
c.1799C>Tp.Ala600Val
missense
Exon 9 of 34ENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152234
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000117
AC:
2
AN:
171258
AF XY:
0.0000107
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000281
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000297
AC:
42
AN:
1415130
Hom.:
0
Cov.:
37
AF XY:
0.0000314
AC XY:
22
AN XY:
699942
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32104
American (AMR)
AF:
0.00
AC:
0
AN:
38142
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25366
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36582
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48014
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5710
European-Non Finnish (NFE)
AF:
0.0000367
AC:
40
AN:
1090316
Other (OTH)
AF:
0.0000170
AC:
1
AN:
58676
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152234
Hom.:
0
Cov.:
34
AF XY:
0.0000269
AC XY:
2
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41468
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000263
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Apr 19, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Uncertain:1
Oct 25, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Uncertain
0.046
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.071
N
LIST_S2
Benign
0.81
T
M_CAP
Pathogenic
0.42
D
MetaRNN
Benign
0.35
T
MetaSVM
Uncertain
-0.043
T
MutationAssessor
Benign
1.6
L
PhyloP100
1.5
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.2
N
REVEL
Uncertain
0.37
Sift
Benign
0.23
T
Sift4G
Benign
0.26
T
Polyphen
0.024
B
Vest4
0.19
MutPred
0.73
Gain of helix (P = 0.0143)
MVP
0.69
ClinPred
0.29
T
GERP RS
4.4
Varity_R
0.098
gMVP
0.37
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759349379; hg19: chr16-1252249; API